Evidence map›Paper›PMID 41163873›Full record

ArticleAnnals of thoracic surgery short reports2025

Resection of Lung Cancer After COVID-19 in a Patient With Severe Chronic Obstructive Pulmonary Disease.

Shumpei Kato, Takashi Sakai, Megumi Kusano, Satoshi Koezuka, Yoko Azuma, Akira Iyoda

Abstract readCase Reports
In one paragraph

Article in Annals of thoracic surgery short reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shumpei KatoDivision of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan.
Takashi SakaiDivision of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan.
Megumi KusanoDivision of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan.
Satoshi KoezukaDivision of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan.
Yoko AzumaDivision of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan.
Akira IyodaDivision of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence regarding the safety of thoracic surgery after COVID-19 is insufficient. The postoperative complication rate is high in patients with comorbidities, including chronic obstructive pulmonary disease, who undergo thoracic surgery. Herein we report a woman with advanced lung cancer associated with severe pulmonary dysfunction with a percentage of predicted forced expiratory volume in 1 second of 44.5% and percentage of predicted diffusion capacity of the lung for carbon monoxide of 38.9% due to chronic obstructive pulmonary disease detected after COVID-19. Curative resection was safely performed with perioperative management including respiratory physiotherapy, inhalation therapy, and adequate preoperative waiting period.

Identifiers

PMID41163873
PMCPMC12559573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.